These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26828750)

  • 41. Prolactin receptor antagonism uncouples lipids from atherosclerosis susceptibility.
    van der Sluis RJ; van den Aardweg T; Reuwer AQ; Twickler MT; Boutillon F; Van Eck M; Goffin V; Hoekstra M
    J Endocrinol; 2014 Sep; 222(3):341-50. PubMed ID: 25063756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis.
    Franco C; Britto K; Wong E; Hou G; Zhu SN; Chen M; Cybulsky MI; Bendeck MP
    Circ Res; 2009 Nov; 105(11):1141-8. PubMed ID: 19834008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG; Zhu Y; Coleman T; Semenkovich CF
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2699-706. PubMed ID: 17951320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Matthijsen RA; de Winther MP; Kuipers D; van der Made I; Weber C; Herias MV; Gijbels MJ; Buurman WA
    Circulation; 2009 Apr; 119(16):2188-95. PubMed ID: 19380618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterizing the Role of Glycogen Synthase Kinase-3α/β in Macrophage Polarization and the Regulation of Pro-Atherogenic Pathways in Cultured Ldlr
    Patel S; Werstuck G
    Front Immunol; 2021; 12():676752. PubMed ID: 34394077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis?
    Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1734-41. PubMed ID: 27386935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse.
    Buono C; Come CE; Stavrakis G; Maguire GF; Connelly PW; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):454-60. PubMed ID: 12615659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective EGFR (Epidermal Growth Factor Receptor) Deletion in Myeloid Cells Limits Atherosclerosis-Brief Report.
    Zeboudj L; Giraud A; Guyonnet L; Zhang Y; Laurans L; Esposito B; Vilar J; Chipont A; Papac-Milicevic N; Binder CJ; Tedgui A; Mallat Z; Tharaux PL; Ait-Oufella H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):114-119. PubMed ID: 29191921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. P2Y6 receptor potentiates pro-inflammatory responses in macrophages and exhibits differential roles in atherosclerotic lesion development.
    Garcia RA; Yan M; Search D; Zhang R; Carson NL; Ryan CS; Smith-Monroy C; Zheng J; Chen J; Kong Y; Tang H; Hellings SE; Wardwell-Swanson J; Dinchuk JE; Psaltis GC; Gordon DA; Glunz PW; Gargalovic PS
    PLoS One; 2014; 9(10):e111385. PubMed ID: 25360548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
    van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M
    Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis.
    Chen HH; Keyhanian K; Zhou X; Vilmundarson RO; Almontashiri NA; Cruz SA; Pandey NR; Lerma Yap N; Ho T; Stewart CA; Huang H; Hari A; Geoffrion M; McPherson R; Rayner KJ; Stewart AF
    Circ Res; 2015 Sep; 117(8):671-83. PubMed ID: 26195219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of one copy of Zfp148 reduces lesional macrophage proliferation and atherosclerosis in mice by activating p53.
    Sayin VI; Khan OM; Pehlivanoglu LE; Staffas A; Ibrahim MX; Asplund A; Agren P; Nilton A; Bergström G; Bergo MO; Borén J; Lindahl P
    Circ Res; 2014 Oct; 115(9):781-9. PubMed ID: 25212213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury.
    Collins AR; Gupte AA; Ji R; Ramirez MR; Minze LJ; Liu JZ; Arredondo M; Ren Y; Deng T; Wang J; Lyon CJ; Hsueh WA
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2839-46. PubMed ID: 23023374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis.
    Barrett TJ; Schlegel M; Zhou F; Gorenchtein M; Bolstorff J; Moore KJ; Fisher EA; Berger JS
    Sci Transl Med; 2019 Nov; 11(517):. PubMed ID: 31694925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor necrosis factor receptor associated factor 6 is not required for atherogenesis in mice and does not associate with atherosclerosis in humans.
    Stachon P; Missiou A; Walter C; Varo N; Colberg C; Wolf D; Buchner M; von Zur Mühlen C; Zirlik K; Bode C; Zirlik A
    PLoS One; 2010 Jul; 5(7):e11589. PubMed ID: 20644648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thiol oxidative stress induced by metabolic disorders amplifies macrophage chemotactic responses and accelerates atherogenesis and kidney injury in LDL receptor-deficient mice.
    Qiao M; Zhao Q; Lee CF; Tannock LR; Smart EJ; LeBaron RG; Phelix CF; Rangel Y; Asmis R
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1779-86. PubMed ID: 19592463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PRMT5 inhibition induces pro-inflammatory macrophage polarization and increased hepatic triglyceride levels without affecting atherosclerosis in mice.
    Zhang Y; Verwilligen RAF; Van Eck M; Hoekstra M
    J Cell Mol Med; 2023 Apr; 27(8):1056-1068. PubMed ID: 36946061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leukocyte Bim deficiency does not impact atherogenesis in ldlr
    Temmerman L; Westra MM; Bot I; van Vlijmen BJM; van Bree N; Bot M; Habets KLL; Keulers TGH; van der Vlag J; Cotter TG; van Berkel TJC; Biessen EAL
    Sci Rep; 2017 Jun; 7(1):3086. PubMed ID: 28596542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia.
    Zhao L; Cuff CA; Moss E; Wille U; Cyrus T; Klein EA; Praticò D; Rader DJ; Hunter CA; Puré E; Funk CD
    J Biol Chem; 2002 Sep; 277(38):35350-6. PubMed ID: 12122008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.